Feasibility of CALM in Patients With Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of PHN-010 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Nudge to Gynecologic Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Cancer Loyalty Card Study 2 (CLOCS-2)
- Status
- RECRUITING
- Phase
- N/A
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
- Status
- RECRUITING
- Phase
- N/A
INSPIRE: a Multi-Cancer Early Detection Study
- Status
- RECRUITING
- Phase
- N/A
Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
- Status
- RECRUITING
- Phase
- PHASE1
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
- Status
- RECRUITING
- Phase
- PHASE4
(GI-RADS) in Preoperative Evaluation of Adnexal Masses
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
- Status
- RECRUITING
- Phase
- N/A
A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2